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Background: Various inflammatory cytokines have been implicated in the pathophysiology of severe ovarian
hyperstimulation syndrome, as well as, various pregnancy complications, including preterm labor, pregnancy
induced hypertension/preeclampsia and intra-uterine growth restriction. We aim to determine whether severe
OHSS, complicated by third space fluid accumulation necessitating drainage, is associated with increased risk of
late obstetrics complications.
Methods: We assessed the obstetrics and neonatal outcome measures of 16 patients admitted to our gynecology
ward during a 6-year period, with severe OHSS complicated by third space fluid accumulation necessitating drainage.
Results: Patients delivered at 37.3 ± 5.9weeks, with a mean birth weight of 3062 ± 757 gr. There was no single case of
gestational diabetes, hypertensive diseases of pregnancy, nor placental abruption. Two (12.5%) patients had preterm
delivery: one at 23 weeks’ gestation and one at 28 weeks’ gestation following preterm premature rupture of membrane.
Another patient experienced an unexplained antepartum fetal death at 27 weeks’ gestation.
Conclusions: Severe OHSS, complicated by third space fluid sequestration necessitating drainage, is not associated
with adverse late pregnancy outcome, except probably for preterm labor. Following resolution of the OHSS,
pregnancies should be regarded as any pregnancy resulting from IVF treatment, with special attention to prevent
preterm labor.
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Ovarian hyperstimulation syndrome (OHSS) is a serious
complication of controlled ovarian hyperstimulation (COH),
almost always presents either after human chorionic
gonadotropin (hCG) administration or during early preg-
nancy. Its co-morbidities result from the marked ovarian
enlargement and the increase in capillary permeability,
with the consequent acute third-space fluid sequestration
[1,2]. Moreover, despite many years of clinical experience,
the pathophysiology of OHSS is poorly understood [3].
While direct action of excessive gonadotropins on
ovarian tissue accounts for the ovarian enlargement,
none of the hitherto reported studies have identified the
cause of the third space fluid-shifting phenomenon. While
the enlarged hyperstimulated ovaries are responsible for
the observed increased prevalence of adnexal torsion,* Correspondence: raoul.orvieto@sheba.health.gov.il
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[4], the most accepted hypothesis assumes that hCG
induces the release of a mediator by gonadotropin-
hyperstimulated ovaries, causing endothelial activation
resulting in increased capillary permeability [5-7]. Several
inflammatory cytokines are present in ascitic fluid of
severe OHSS patients [8] and were shown to correlate with
OHSS severity [9]. Moreover, inflammatory mediators,
namely, C-reactive protein, leukocyte and endothelial selec-
tins and vascular endothelial growth factor are increased
after hCG administration in vivo, reflecting an inflamma-
tory state, neutrophil and endothelial activations, respect-
ively [6,10]. However, no significant evidence exists to
prove any role of these regulators as a culprit of OHSS.
Various inflammatory cytokines, including vascular
endothelial growth factor, have been implicated in the
pathophysiology of several late pregnancy complica-
tions, including preterm labor [11], pregnancy induced
hypertension/preeclampsia [12] and intra-uterine growthd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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increase in systemic inflammatory cytokines that induces
a systemic inflammatory response [6], a common cause/
mechanism may attribute to both severe OHSS with
vascular hyper-permeability and the aforementioned
pregnancy complications.
The hitherto published literature regarding the relation
between OHSS and pregnancy complications is limited
and controversial [14-17]. This disparity in the observed
outcomes probably results from the inclusion of patients
with OHSS, not exclusively limited to those with signifi-
cant increase in vascular permeability, as reflected by third
space fluid accumulation necessitating drainage.
Prompted by the aforementioned observations, we sought
to address whether severe OHSS, complicated by third
space fluid accumulation necessitating drainage), is associ-
ated with increased risk of late obstetrical complications.Methods
We reviewed the medical files of all consecutive women
admitted to our gynecology ward, during a 6 year period,
due to severe OHSS following an in-vitro fertilization
(IVF) treatment. Severe OHSS was defined according to
Golan et al. [18] and Navot et al. [1] criteria, while early
and late OHSS were defined according to Lyons et al.
[19]: 3–7 days and 12–17 days following HCG ovulation
triggering, respectively.
The elimination of bias in this selection, for the pur-
poses of this study, was achieved by analyzing only those
admitted with Hct level >40%, whose medical condition
necessitated ascitic or pleural fluid drainage. Moreover,
only those with singleton pregnancy that continued
beyond the first trimester were included.
Data on patients’ demographics, infertility, obstetrical
and neonatal related variables were collected from the
files. Gestational age was calculated based on the day of
ovum pick-up (2 weeks gestation) and was correlated to
a first trimester ultrasound exam. Results are presented
as mean ± standard deviation. The study was approved
by the Institutional Research Ethics Board of our center.Results
During the study period 16 patients were hospitalized
following IVF treatments due to severe OHSS necessi-
tating ascetic or pleural fluid drainage. Mean patients’
age and body mass index were 30.8 ± 4.7 years and
21.8 ± 3.0 kg/m2, respectively. Causes of infertility were
anovulation/ polycystic ovary syndrome in 25%, male
factor infertility in 31.25% and others (unexplained,
endometriosis, etc.) in 43.75% of the study group, with
10 (62.5%) of whom suffering from primary infertility. All
underwent an IVF treatment with retrievals of 18 ± 5.9
oocytes and transfers of 2.2 ± 6 embryos.Patients were admitted to our gynecology wards
14.5 + 4.7 days after HCG administration, 13 with late
and 3 with early and late severe OHSS. They were hos-
pitalized for 11.9 + 4.8 days, with a mean hematocrit
level on admission of 43.8% + 2.0%.
During hospitalization, 14 underwent ascitic and 2
pleural fluid drainages. Moreover, 6 patients showed
abnormally elevated liver enzymes, one suffered from
oliguria, 2 had adnexal torsion and another pair suffered
from thromboembolic complications (jugular and sub-
clavian thrombosis).
Regarding the perinatal outcome, patients delivered at
mean gestational age of 37.3 ± 5.9 weeks, with a mean
birth weight of 3062 ± 757 gr and 1 and 5 minutes APGAR
scores of 8.4 ± 2.3 and 9.3 ± 2.6, respectively. There was
no single case of gestational diabetes, hypertensive dis-
eases of pregnancy, nor placental abruption. Two (12.5%)
patients had preterm delivery (<37 weeks): one at 23 weeks’
gestation and one at 28 weeks’ gestation following pre-
term premature rupture of membrane. A healthy baby
was born, weighing 1202 gr with an APGAR score of
9/10. Another patient experienced an unexplained
antepartum fetal death at 27 weeks’ gestation (with no
gross fetal anomalies, normal thrombophilia evaluation
and no autopsy due to parents refusal),
While 8 (50%) patients experienced a spontaneous vagi-
nal delivery, 7 (43.75%) delivered by cesarean section and
one by instrumental delivery. The indications for cesarean
deliveries were either non-reassuring fetal status (n = 6),
or maternal request (n = 1).Discussion
In the present study of patients with severe OHSS undergo-
ing ascitic or pleural fluid drainage, we actually evaluated
patients with the most severe form of OHSS, as reflected
by the highest number of oocytes retrieved during their IVF
treatment (18 ± 5.9 vs 13 ± 5.2, 13.7 ± 5.2 and 16.8 ± 5.9 oo-
cytes) and the longest hospitalization period (11.9 ± 4.8 vs
10.2 ± 7.2 and 4.5 ± 2.9 and 6.6 ± 4.71 days), as compared
to the hitherto published studies [16,15,17], respectively.
Moreover, a closer look at the aforementioned studies
(Table 1) reveals that none of them related exclusively to
patients who underwent ascitic or pleural fluid drainage,
with no mention on the prevalence of those (with single-
ton pregnancy) undergoing drainage [15-17]. Moreover,
two studies did not differentiate between singleton and
twin pregnancies [14,16].
While our study group of patients with the most severe
form of OHSS demonstrated all the well-documented
complications, namely, elevated liver enzymes, oliguria,
adnexal torsion and thromboembolism, no single case of
gestational diabetes, hypertensive diseases of pregnancy,
or placental abruption was observed.
Table 1 Summary of the hitherto published studies relating to pregnancy complications in patients with severe OHSS
Abramov et al. [14] Wiser et al. [15] Courbiere et al. [16] Haas et al. [17] Present study
All pregnancies 125
Number of pregnancies 68 165 40
Gestational age at delivery (weeks) 35.8 ± 3.0 37 ± 1.5
Birth weight (grams) 2221 ± 252
Cesarean Section rate (%) 44.1
Preterm labor < 37 wks (%) 44 36
Hypertensive diseases of pregnancy (%) 13.2 21.2
IUGR (%) 1.5
Gestational Diabetes (%) 5.9 6
IUFD (%) 1.5
Adnexal torsion (%) 5 4.8
Thromboembolism (%) 1.5 10 1.6
Paracentesis (%) 2.5 32.8
Singleton pregnancies
Number of pregnancies 29 101 31 78 16
Gestational age at delivery (weeks) 37.2 ± 3.2 39 ± 1.9 37.9 ± 3.3
Birth weight (grams) 2785 ± 356 3045 ± 544 3032 ± 545 2854 ± 610 37.3 ± 5.9
Cesarean Section rate (%) 24.1 24 28.2 43.75
Preterm labor < 37 wks (%) 28 1 20.5 12.5
Hypertensive diseases of pregnancy (%) 6.9 8.9 0
IUGR (%) 2.6
Gestational Diabetes (%) 9.9 17.9 0
IUFD (%) 1.2 6.2
Adnexal torstion (%) 12.5
Thromboembolism (%) 6.2
Paracentesis (%) 100
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singleton pregnancies complicated by severe OHSS, ne-
cessitating ascitic or pleural fluid drainage, are not at risk
for obstetric complications, except probably for preterm
labor. While, studies relating to hypertensive diseases of
pregnancy, gestational diabetes and IUGR show contra-
dictory results [14-17], the observed increased prevalence
of preterm labor (12.5%) in our study, is in accordance
with previous studies [14,16,17], and is also a well-known
complication of IVF pregnancies in general [20]. More-
over, the observed single case of unexplained antepartum
fetal death requires attention and raises the question
whether it is accidental or is associated to severe OHSS.
Despite the small sample size and the inherent disad-
vantages of a retrospective study design, we would expect a
significantly higher prevalence of these obstetric complica-
tions among this subgroup of severe OHSS patients with
”endothelial” activation, as reflected by the third space fluid
sequestration, necessitating drainage. The observed lack of
association between severe OHSS complicated with thirdspace fluid sequestration and an increased prevalence of
the aforementioned obstetric complications, except prob-
ably for preterm labor, actually excludes the possibility of a
common mechanism responsible for these abnormalities.
Conclusions
To conclude, we have demonstrated that severe OHSS,
complicated by third space fluid sequestration necessitat-
ing drainage, is not associated with adverse late pregnancy
outcome (i.e. intrauterine growth restriction and pregnancy
induced hypertension/preeclampsia), except for preterm
labor. Following resolution of the OHSS, pregnancies
should be regarded as any pregnancy resulting from IVF
treatment, with special attention to identify and treat pre-
term birth. Further large prospective studies are required
in order to determine whether severe OHSS complicated
with third space fluid sequestration, is associated with late
pregnancy complications or whether there are preexisting
factors predisposing women to develop both OHSS and
various pregnancy complications.
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